Journal

Palliative medicine
ISSN: 1477-030X
Titre abrégé: Palliat Med
Pays: England
ID NLM: 8704926

Informations de publication

Date de publication:
01 2022
Historique:
pubmed: 20 10 2021
medline: 28 1 2022
entrez: 19 10 2021
Statut: ppublish

Résumé

People living with cancer that is treatable but not curable have complex needs, often managing health at home, supported by those close to them. Challenges are likely to be exacerbated during the COVID-19 pandemic and the risk-reducing measures introduced in response. The impact of COVID-19 on those living with incurable, life-threatening conditions is little understood. To investigate the experiences and identify the impact of the COVID-19 pandemic for people living with treatable not curable cancer and their informal carers. Qualitative semi-structured phone interviews were conducted with 21 patients living with cancer that is treatable but not curable and 14 carers. Participants were part of a larger longitudinal qualitative study (ENABLE) on supported self-management for people living with cancer that is treatable but not curable. The COVID-19 pandemic magnified uncertainty and anxiety and led to loss of opportunities to do things important to patients in the limited time they have left to live. Lack of face-to-face contact with loved ones had a significant impact on patients' and carers' emotional wellbeing. Carers experienced increased responsibilities but less access to formal and informal support and respite. While changes to treatment led to some concern about longer-term impact on health, most patients felt well-supported by healthcare teams. The study provides rich insights into the nature of challenges, uncertainty and lost opportunities resulting from the COVID-19 pandemic for patients and carers living with cancer that is treatable but not curable, which has wider resonance for people living with other life-limiting conditions.

Sections du résumé

BACKGROUND
People living with cancer that is treatable but not curable have complex needs, often managing health at home, supported by those close to them. Challenges are likely to be exacerbated during the COVID-19 pandemic and the risk-reducing measures introduced in response. The impact of COVID-19 on those living with incurable, life-threatening conditions is little understood.
AIM
To investigate the experiences and identify the impact of the COVID-19 pandemic for people living with treatable not curable cancer and their informal carers.
DESIGN
Qualitative semi-structured phone interviews were conducted with 21 patients living with cancer that is treatable but not curable and 14 carers.
SETTING/ PARTICIPANTS
Participants were part of a larger longitudinal qualitative study (ENABLE) on supported self-management for people living with cancer that is treatable but not curable.
RESULTS
The COVID-19 pandemic magnified uncertainty and anxiety and led to loss of opportunities to do things important to patients in the limited time they have left to live. Lack of face-to-face contact with loved ones had a significant impact on patients' and carers' emotional wellbeing. Carers experienced increased responsibilities but less access to formal and informal support and respite. While changes to treatment led to some concern about longer-term impact on health, most patients felt well-supported by healthcare teams.
CONCLUSION
The study provides rich insights into the nature of challenges, uncertainty and lost opportunities resulting from the COVID-19 pandemic for patients and carers living with cancer that is treatable but not curable, which has wider resonance for people living with other life-limiting conditions.

Identifiants

pubmed: 34664537
doi: 10.1177/02692163211049497
pmc: PMC8796164
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

152-160

Références

BMJ Support Palliat Care. 2015 Dec;5(4):343-50
pubmed: 26586683
Palliat Med. 2022 Jan;36(1):152-160
pubmed: 34664537
Eur J Cancer Care (Engl). 2020 Mar;29(2):e13217
pubmed: 31958343
J Cancer Surviv. 2020 Oct;14(5):601-606
pubmed: 32335850
Front Psychol. 2020 Aug 24;11:2033
pubmed: 32982846
BMJ Open. 2021 Jan 31;11(1):e041070
pubmed: 33518518
Curr Oncol Rep. 2020 May 8;22(5):53
pubmed: 32385672
Oncol Lett. 2020 Jul;20(1):441-447
pubmed: 32565968
Int J Qual Health Care. 2007 Dec;19(6):349-57
pubmed: 17872937
J Pain Symptom Manage. 2021 Sep;62(3):460-470
pubmed: 33556496
Cancer Discov. 2020 Jun;10(6):783-791
pubmed: 32345594
BMJ Open. 2018 Oct 8;8(10):e019993
pubmed: 30297341
Palliat Med. 2021 May;35(5):814-829
pubmed: 33754892
Lancet Oncol. 2020 Aug;21(8):1035-1044
pubmed: 32702311
Psychooncology. 2020 Sep;29(9):1387-1392
pubmed: 32544285
BMJ Open. 2017 Nov 22;7(11):e016797
pubmed: 29170285
JCO Glob Oncol. 2020 Oct;6:1494-1509
pubmed: 33017179
PLoS One. 2017 Jan 20;12(1):e0169071
pubmed: 28107352
Implement Sci. 2019 Feb 1;14(1):11
pubmed: 30709368
Nat Med. 2020 Jul;26(7):1146
pubmed: 32494062
BMJ Support Palliat Care. 2015 Dec;5(4):322-4
pubmed: 26586680
Lancet Oncol. 2020 Mar;21(3):335-337
pubmed: 32066541
Eur J Cancer Care (Engl). 2016 Jan;25(1):122-31
pubmed: 25070508
J Cancer Surviv. 2017 Oct;11(5):590-603
pubmed: 28721677
Support Care Cancer. 2016 May;24(5):2017-2024
pubmed: 26530227
Eur J Cancer Care (Engl). 2021 Sep;30(5):e13442
pubmed: 33764611
Semin Oncol Nurs. 2010 Aug;26(3):144-50
pubmed: 20656137
Support Care Cancer. 2012 Aug;20(8):1619-27
pubmed: 21866426

Auteurs

Eloise Radcliffe (E)

University of Southampton, Southampton, UK.

Aysha Khan (A)

The Christie NHS Foundation Trust, Manchester, UK.

David Wright (D)

University of Southampton, Southampton, UK.

Richard Berman (R)

The Christie NHS Foundation Trust, Manchester, UK.

Sara Demain (S)

University of Southampton, Southampton, UK.

Claire Foster (C)

University of Southampton, Southampton, UK.

Susan Restorick-Banks (S)

Patient Representative, Southampton, UK.

Alison Richardson (A)

University of Southampton, Southampton, UK.

Richard Wagland (R)

University of Southampton, Southampton, UK.

Lynn Calman (L)

University of Southampton, Southampton, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH